286 related articles for article (PubMed ID: 26517439)
1. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
[TBL] [Abstract][Full Text] [Related]
2. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
3. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
4. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
6. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
8. Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study.
Rose A; El-Leithy T; vom Dorp F; Zakaria A; Eisenhardt A; Tschirdewahn S; Rübben H
J Urol; 2015 Oct; 194(4):939-43. PubMed ID: 25910967
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
[TBL] [Abstract][Full Text] [Related]
10. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
11. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
13. Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts--a case report.
Werthmann PG; Sträter G; Friesland H; Kienle GS
Phytomedicine; 2013 Feb; 20(3-4):324-7. PubMed ID: 23394841
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
Elsässer-Beile U; Leiber C; Wolf P; Lucht M; Mengs U; Wetterauer U
J Urol; 2005 Jul; 174(1):76-9. PubMed ID: 15947582
[TBL] [Abstract][Full Text] [Related]
15. Prolonged cytotoxic effect of aqueous extracts from dried viscum album on bladder cancer cells.
Hunziker-Basler N; Zuzak TJ; Eggenschwiler J; Rist L; Simões-Wüst AP; Viviani A
Pharmazie; 2007 Mar; 62(3):237-8. PubMed ID: 17416204
[TBL] [Abstract][Full Text] [Related]
16. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
Glardon ; Pache ; Magnenat ; Pin ; Parvis
Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
[TBL] [Abstract][Full Text] [Related]
17. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.
Twardziok M; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
PLoS One; 2016; 11(9):e0159749. PubMed ID: 27589063
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Tumor-Free Survival in a Patient with Stage IV Epithelial Ovarian Cancer Undergoing High-Dose Chemotherapy and Viscum album Extract Treatment: A Case Report.
Werthmann PG; Kempenich R; Kienle GS
Perm J; 2018; 23():18-025. PubMed ID: 30589407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
